Analysis and Commentary STEVEN GROSSMAN 5/5/17 Analysis and Commentary STEVEN GROSSMAN 5/5/17 Time for Some Heartfelt "Thank you"s Read More Advocacy at a Glance STEVEN GROSSMAN 5/5/17 Advocacy at a Glance STEVEN GROSSMAN 5/5/17 FY 17 Omnibus Becomes Law; Brings Funding Support for FDA and more Read More Advocacy at a Glance STEVEN GROSSMAN 4/28/17 Advocacy at a Glance STEVEN GROSSMAN 4/28/17 Alliance Capitol Hill Advocacy Day is a Success and more Read More Advocacy at a Glance STEVEN GROSSMAN 4/14/17 Advocacy at a Glance STEVEN GROSSMAN 4/14/17 Alliance Has Thoughtful Discussion with OMB and more Read More Analysis and Commentary STEVEN GROSSMAN 3/31/17 Analysis and Commentary STEVEN GROSSMAN 3/31/17 President Trump's FY 18 Proposed Budget: More Qs and More As Read More Advocacy at a Glance STEVEN GROSSMAN 3/31/17 Advocacy at a Glance STEVEN GROSSMAN 3/31/17 The FY17 Continuing Resolution Expires Soon and more Read More Advocacy at a Glance STEVEN GROSSMAN 1/13/17 Advocacy at a Glance STEVEN GROSSMAN 1/13/17 Sequester May Follow April 28 Expiration of FY 17 CR Read More Advocacy at a Glance STEVEN GROSSMAN 12/16/16 Advocacy at a Glance STEVEN GROSSMAN 12/16/16 FY 17 Continuing Resolution to Run Through April 28, 2017 Read More Advocacy at a Glance STEVEN GROSSMAN 12/9/16 Advocacy at a Glance STEVEN GROSSMAN 12/9/16 Continuing Resolution Close, But May Not Make Friday Night Deadline Read More Advocacy at a Glance STEVEN GROSSMAN 12/5/16 Advocacy at a Glance STEVEN GROSSMAN 12/5/16 21st Century Cures Passes House; Set for Senate Vote Next Week Read More Advocacy at a Glance STEVEN GROSSMAN 11/21/16 Advocacy at a Glance STEVEN GROSSMAN 11/21/16 Short-Term Continuing Resolution Likely Read More Advocacy at a Glance STEVEN GROSSMAN 11/11/16 Advocacy at a Glance STEVEN GROSSMAN 11/11/16 Mr. Trump, the Election and FDA Read More Analysis and Commentary STEVEN GROSSMAN 11/7/16 Analysis and Commentary STEVEN GROSSMAN 11/7/16 Alliance Has No Prognosis for the Lame Duck Read More Advocacy at a Glance STEVEN GROSSMAN 11/7/16 Advocacy at a Glance STEVEN GROSSMAN 11/7/16 FDA and the Elections: Many Unknowns Read More Advocacy at a Glance STEVEN GROSSMAN 10/28/16 Advocacy at a Glance STEVEN GROSSMAN 10/28/16 Down-Ballot Congressional Races: Another Post-Election Unknown Read More Advocacy at a Glance STEVEN GROSSMAN 10/1/16 Advocacy at a Glance STEVEN GROSSMAN 10/1/16 A CR Gets Passed ... But Has Fiscal Implications Read More Advocacy at a Glance STEVEN GROSSMAN 10/1/16 Advocacy at a Glance STEVEN GROSSMAN 10/1/16 CR through December 9 Passes; Congress in Recess Read More Advocacy at a Glance STEVEN GROSSMAN 9/23/16 Advocacy at a Glance STEVEN GROSSMAN 9/23/16 Continuing Resolution Still in Negotiations; One Week to Go or Else Read More Analysis and Commentary STEVEN GROSSMAN 9/16/16 Analysis and Commentary STEVEN GROSSMAN 9/16/16 What to Expect When You are Expecting a Lame Duck Read More Advocacy at a Glance STEVEN GROSSMAN 9/16/16 Advocacy at a Glance STEVEN GROSSMAN 9/16/16 Alliance District Lobby Days Planned for Mid-October. Please Participate Read More Older Posts
Analysis and Commentary STEVEN GROSSMAN 5/5/17 Analysis and Commentary STEVEN GROSSMAN 5/5/17 Time for Some Heartfelt "Thank you"s Read More
Advocacy at a Glance STEVEN GROSSMAN 5/5/17 Advocacy at a Glance STEVEN GROSSMAN 5/5/17 FY 17 Omnibus Becomes Law; Brings Funding Support for FDA and more Read More
Advocacy at a Glance STEVEN GROSSMAN 4/28/17 Advocacy at a Glance STEVEN GROSSMAN 4/28/17 Alliance Capitol Hill Advocacy Day is a Success and more Read More
Advocacy at a Glance STEVEN GROSSMAN 4/14/17 Advocacy at a Glance STEVEN GROSSMAN 4/14/17 Alliance Has Thoughtful Discussion with OMB and more Read More
Analysis and Commentary STEVEN GROSSMAN 3/31/17 Analysis and Commentary STEVEN GROSSMAN 3/31/17 President Trump's FY 18 Proposed Budget: More Qs and More As Read More
Advocacy at a Glance STEVEN GROSSMAN 3/31/17 Advocacy at a Glance STEVEN GROSSMAN 3/31/17 The FY17 Continuing Resolution Expires Soon and more Read More
Advocacy at a Glance STEVEN GROSSMAN 1/13/17 Advocacy at a Glance STEVEN GROSSMAN 1/13/17 Sequester May Follow April 28 Expiration of FY 17 CR Read More
Advocacy at a Glance STEVEN GROSSMAN 12/16/16 Advocacy at a Glance STEVEN GROSSMAN 12/16/16 FY 17 Continuing Resolution to Run Through April 28, 2017 Read More
Advocacy at a Glance STEVEN GROSSMAN 12/9/16 Advocacy at a Glance STEVEN GROSSMAN 12/9/16 Continuing Resolution Close, But May Not Make Friday Night Deadline Read More
Advocacy at a Glance STEVEN GROSSMAN 12/5/16 Advocacy at a Glance STEVEN GROSSMAN 12/5/16 21st Century Cures Passes House; Set for Senate Vote Next Week Read More
Advocacy at a Glance STEVEN GROSSMAN 11/21/16 Advocacy at a Glance STEVEN GROSSMAN 11/21/16 Short-Term Continuing Resolution Likely Read More
Advocacy at a Glance STEVEN GROSSMAN 11/11/16 Advocacy at a Glance STEVEN GROSSMAN 11/11/16 Mr. Trump, the Election and FDA Read More
Analysis and Commentary STEVEN GROSSMAN 11/7/16 Analysis and Commentary STEVEN GROSSMAN 11/7/16 Alliance Has No Prognosis for the Lame Duck Read More
Advocacy at a Glance STEVEN GROSSMAN 11/7/16 Advocacy at a Glance STEVEN GROSSMAN 11/7/16 FDA and the Elections: Many Unknowns Read More
Advocacy at a Glance STEVEN GROSSMAN 10/28/16 Advocacy at a Glance STEVEN GROSSMAN 10/28/16 Down-Ballot Congressional Races: Another Post-Election Unknown Read More
Advocacy at a Glance STEVEN GROSSMAN 10/1/16 Advocacy at a Glance STEVEN GROSSMAN 10/1/16 A CR Gets Passed ... But Has Fiscal Implications Read More
Advocacy at a Glance STEVEN GROSSMAN 10/1/16 Advocacy at a Glance STEVEN GROSSMAN 10/1/16 CR through December 9 Passes; Congress in Recess Read More
Advocacy at a Glance STEVEN GROSSMAN 9/23/16 Advocacy at a Glance STEVEN GROSSMAN 9/23/16 Continuing Resolution Still in Negotiations; One Week to Go or Else Read More
Analysis and Commentary STEVEN GROSSMAN 9/16/16 Analysis and Commentary STEVEN GROSSMAN 9/16/16 What to Expect When You are Expecting a Lame Duck Read More
Advocacy at a Glance STEVEN GROSSMAN 9/16/16 Advocacy at a Glance STEVEN GROSSMAN 9/16/16 Alliance District Lobby Days Planned for Mid-October. Please Participate Read More
